Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Analysis of genomic dose-response information on arsenic to inform key events in a mode of action for carcinogenicity.

Gentry PR, McDonald TB, Sullivan DE, Shipp AM, Yager JW, Clewell HJ 3rd.

Environ Mol Mutagen. 2010 Jan;51(1):1-14. doi: 10.1002/em.20505. Review.

2.
3.
4.

Research toward the development of a biologically based dose response assessment for inorganic arsenic carcinogenicity: a progress report.

Clewell HJ, Thomas RS, Gentry PR, Crump KS, Kenyon EM, El-Masri HA, Yager JW.

Toxicol Appl Pharmacol. 2007 Aug 1;222(3):388-98. Epub 2007 Mar 30.

PMID:
17499324
5.

Biomarkers in aquatic plants: selection and utility.

Brain RA, Cedergreen N.

Rev Environ Contam Toxicol. 2009;198:49-109. doi: 10.1007/978-0-387-09647-6_2. Review.

PMID:
19253039
6.

Relationships between genomic, cell cycle, and mutagenic responses of TK6 cells exposed to DNA damaging chemicals.

Islaih M, Halstead BW, Kadura IA, Li B, Reid-Hubbard JL, Flick L, Altizer JL, Thom Deahl J, Monteith DK, Newton RK, Watson DE.

Mutat Res. 2005 Oct 15;578(1-2):100-16.

PMID:
16109433
7.

Gene expression profiling of responses to dimethylarsinic acid in female F344 rat urothelium.

Sen B, Wang A, Hester SD, Robertson JL, Wolf DC.

Toxicology. 2005 Nov 15;215(3):214-26. Epub 2005 Aug 24. Erratum in: Toxicology. 2006 Mar 15;220(2-3):240-1.

PMID:
16122865
8.

Study of gene expression profiles in TK6 human cells exposed to DNA-oxidizing agents.

Platel A, Gervais V, Sajot N, Nesslany F, Marzin D, Claude N.

Mutat Res. 2010 Jul 7;689(1-2):21-49. doi: 10.1016/j.mrfmmm.2010.04.004. Epub 2010 May 11.

PMID:
20466008
9.

Genome-wide analysis of BEAS-2B cells exposed to trivalent arsenicals and dimethylthioarsinic acid.

Chilakapati J, Wallace K, Ren H, Fricke M, Bailey K, Ward W, Creed J, Kitchin K.

Toxicology. 2010 Jan 31;268(1-2):31-9. doi: 10.1016/j.tox.2009.11.018. Epub 2009 Nov 27.

PMID:
19945496
10.
11.

Arsenic, mode of action at biologically plausible low doses: what are the implications for low dose cancer risk?

Snow ET, Sykora P, Durham TR, Klein CB.

Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):557-64. Review.

PMID:
15996700
12.

Identification of interspecies concordance of mechanisms of arsenic-induced bladder cancer.

Sen B, Wolf DC, Turpaz Y, Bugrim A, Retief J, Hester SD.

Toxicol In Vitro. 2007 Dec;21(8):1513-29. Epub 2007 Jul 21.

PMID:
17720352
13.

Molecular and genetic toxicology of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).

Gooderham NJ, Zhu H, Lauber S, Boyce A, Creton S.

Mutat Res. 2002 Sep 30;506-507:91-9. Review.

PMID:
12351148
14.

Hypoxia down-regulates DNA double strand break repair gene expression in prostate cancer cells.

Meng AX, Jalali F, Cuddihy A, Chan N, Bindra RS, Glazer PM, Bristow RG.

Radiother Oncol. 2005 Aug;76(2):168-76.

PMID:
16026872
16.

Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC).

Khodarev NN, Kataoka Y, Murley JS, Weichselbaum RR, Grdina DJ.

Int J Radiat Oncol Biol Phys. 2004 Oct 1;60(2):553-63.

PMID:
15380592
17.
18.

DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines.

Delmastro DA, Li J, Vaisman A, Solle M, Chaney SG.

Cancer Chemother Pharmacol. 1997;39(3):245-53.

PMID:
8996528
20.

Mechanisms of benzene-induced hematotoxicity and leukemogenicity: cDNA microarray analyses using mouse bone marrow tissue.

Yoon BI, Li GX, Kitada K, Kawasaki Y, Igarashi K, Kodama Y, Inoue T, Kobayashi K, Kanno J, Kim DY, Inoue T, Hirabayashi Y.

Environ Health Perspect. 2003 Aug;111(11):1411-20.

Supplemental Content

Support Center